<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>新康界 | wechat-feeds</title><link>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</link><description>中康资讯旗下品牌，中国领先的医药健康产业财经新媒体。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 13 Mar 2021 01:01:28 +0800</pubDate><image><url>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</url><title>新康界 | wechat-feeds</title><link>http://MzA5ODEzOTYxNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>CDK4/6抑制剂是乳腺癌领域的下一个黄金赛道吗？</title><link>https://mp.weixin.qq.com/s/poPvFKRlTUZVdbSjrph9cw</link><description></description><content:encoded><![CDATA[CDK4/6抑制剂是乳腺癌领域的下一个黄金赛道吗？]]></content:encoded><pubDate>Fri, 12 Mar 2021 23:03:52 +0800</pubDate></item><item><title>医药行业政策回顾（0220-0312）</title><link>https://mp.weixin.qq.com/s/LYc-SAsA0cgaIHp68Cox6Q</link><description></description><content:encoded><![CDATA[医药行业政策回顾（0220-0312）]]></content:encoded><pubDate>Fri, 12 Mar 2021 23:03:52 +0800</pubDate></item><item><title>专访王如伟：持续领跑  跨越未来——中国医药创新下半场  商业化是核心竞争力</title><link>https://mp.weixin.qq.com/s/eFt71JtlGY-nSF8_uoRDYw</link><description></description><content:encoded><![CDATA[专访王如伟：持续领跑  跨越未来——中国医药创新下半场  商业化是核心竞争力]]></content:encoded><pubDate>Thu, 11 Mar 2021 15:44:08 +0800</pubDate></item><item><title>中康CMH | 2月新闻荟萃&amp;药品市场数据回顾</title><link>https://mp.weixin.qq.com/s/XZcWIMPwAFjHHRGM9VXDEQ</link><description></description><content:encoded><![CDATA[中康CMH | 2月新闻荟萃&药品市场数据回顾]]></content:encoded><pubDate>Thu, 11 Mar 2021 15:44:08 +0800</pubDate></item><item><title>超强剧透！！！大咖纷纷坐镇第十届中国医疗健康产业投资与并购CEO峰会</title><link>https://mp.weixin.qq.com/s/bBh92b2P5-rPAn83BBddJg</link><description></description><content:encoded><![CDATA[超强剧透！！！大咖纷纷坐镇第十届中国医疗健康产业投资与并购CEO峰会]]></content:encoded><pubDate>Thu, 11 Mar 2021 15:44:08 +0800</pubDate></item><item><title>大健康产业投资并购动态周报Vol.41</title><link>https://mp.weixin.qq.com/s/22jjamKO5L3dYBs3phP6Jw</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态周报Vol.41]]></content:encoded><pubDate>Wed, 10 Mar 2021 20:02:25 +0800</pubDate></item><item><title>燃！MDx2021首批嘉宾揭晓 | 药监局/卫健委/疾控中心/金域/致善/博奥生物/优思达等嘉宾确认出席！</title><link>https://mp.weixin.qq.com/s/a4Qu-N2YvtLza3UeKs_0yQ</link><description></description><content:encoded><![CDATA[燃！MDx2021首批嘉宾揭晓 | 药监局/卫健委/疾控中心/金域/致善/博奥生物/优思达等嘉宾确认出席！]]></content:encoded><pubDate>Wed, 10 Mar 2021 20:02:25 +0800</pubDate></item><item><title>2021政府工作报告透露医药健康行业六大趋势</title><link>https://mp.weixin.qq.com/s/uO5bt6A9H1ACezXUcdgDRQ</link><description></description><content:encoded><![CDATA[2021政府工作报告透露医药健康行业六大趋势]]></content:encoded><pubDate>Sat, 06 Mar 2021 20:25:49 +0800</pubDate></item><item><title>糖尿病领域神仙打架，GLP-1RA赛道战火重燃</title><link>https://mp.weixin.qq.com/s/7qTvp17XgO7BzabxzSIn2w</link><description></description><content:encoded><![CDATA[糖尿病领域神仙打架，GLP-1RA赛道战火重燃]]></content:encoded><pubDate>Fri, 05 Mar 2021 23:08:20 +0800</pubDate></item><item><title>三度递表！温州牙科医疗服务区域龙头冲击港股IPO</title><link>https://mp.weixin.qq.com/s/32tD7JqF9RIHPIkXo-DJUw</link><description></description><content:encoded><![CDATA[三度递表！温州牙科医疗服务区域龙头冲击港股IPO]]></content:encoded><pubDate>Wed, 03 Mar 2021 20:33:40 +0800</pubDate></item><item><title>更好地发挥医保作用 推动三医协调改革</title><link>https://mp.weixin.qq.com/s/cE89PiAtFY_ze2nr6zbELQ</link><description></description><content:encoded><![CDATA[更好地发挥医保作用 推动三医协调改革]]></content:encoded><pubDate>Wed, 03 Mar 2021 20:33:40 +0800</pubDate></item><item><title>大健康产业投资并购动态周报Vol.40</title><link>https://mp.weixin.qq.com/s/Y8haOKbTAskGpfAOeYfauw</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态周报Vol.40]]></content:encoded><pubDate>Tue, 02 Mar 2021 21:03:21 +0800</pubDate></item><item><title>新冠疫苗渐次上市，治疗药物缘何音讯寥落？</title><link>https://mp.weixin.qq.com/s/PUGj7hoBhpufHkAmWw2KmA</link><description></description><content:encoded><![CDATA[新冠疫苗渐次上市，治疗药物缘何音讯寥落？]]></content:encoded><pubDate>Mon, 01 Mar 2021 19:27:22 +0800</pubDate></item><item><title>大幅回调的背后，我们仍坚持看好连锁药店赛道！</title><link>https://mp.weixin.qq.com/s/pGmOA0YbakcY8LlFy_lGsg</link><description></description><content:encoded><![CDATA[大幅回调的背后，我们仍坚持看好连锁药店赛道！]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:42:01 +0800</pubDate></item><item><title>大健康产业投资并购动态双周报Vol.39</title><link>https://mp.weixin.qq.com/s/Vo54eGJ_FOPsZy8xWLQ20Q</link><description></description><content:encoded><![CDATA[大健康产业投资并购动态双周报Vol.39]]></content:encoded><pubDate>Tue, 23 Feb 2021 22:45:50 +0800</pubDate></item><item><title>医药CXO产业图谱分析：需求强劲，小分子CDMO崛起</title><link>https://mp.weixin.qq.com/s/CgOK_X1IsGF80eiATxehMQ</link><description></description><content:encoded><![CDATA[医药CXO产业图谱分析：需求强劲，小分子CDMO崛起]]></content:encoded><pubDate>Tue, 23 Feb 2021 22:45:50 +0800</pubDate></item></channel></rss>